BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02413827-completion@plaintrial.com
DTSTAMP:20261028T002143Z
DTSTART;VALUE=DATE:20161109
SUMMARY:A Study of Varlilumab (Anti-CD27) and Ipilimumab and CDX-1401 in Pa
 tients With Unresectable Stage III or IV Melanoma — estimated completion
  date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT02413827
URL:https://plaintrial.com/trial/NCT02413827
END:VEVENT
END:VCALENDAR